A delay in the FDA decision for NT-501 could leave those with macular telangiectasia (MacTel) without any form of treatment ...
NT-501 is an investigational ocular implant that utilizes an encapsulated cell-based delivery system to deliver continuous ciliary neurotrophic factor.
GlobalData on MSN4d
FDA delays priority review of Neurotech’s eye cell therapy implantThe US regulatory agency has pushed the PDUFA date by three months to 18 March 2025 to “allow for more time to review ...
Considering taking supplements to treat macular telangiectasia type 2? Below is a list of common natural remedies used to treat or reduce the symptoms of macular telangiectasia type 2. Follow the ...
Neurotech Pharmaceuticals, Inc., an innovator in sustained drug delivery for chronic retinal diseases, today announced that the U.S. Food and Drug Administration (FDA), has extended the Prescription ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback